PPH: Key Pharmaceutical Innovations Support Bullish Outlook (NASDAQ:PPH)
· seekingalpha.com
PPH's concentrated exposure to Eli Lilly, Merck, and Novo Nordisk provides key catalysts. Find out why PPH ETF warrants a Buy rating.
Wilson Research seeks to provide investors with focused insights on predominantly exchange-traded funds, or ETFs, with a blend between growth potential and divi...